Recently, GE Healthcare announced the acquisition of BK Medical in the field of surgical visualization from Altaris Capital Partners for a cash purchase price of US$1.45 billion. This acquisition is expected to help GE Healthcare expand its ultrasound product portfolio into the field of surgical visualization.
BK Medical is a global innovator of intraoperative imaging and surgical navigation. The company's technology can provide imaging support during surgery, allowing doctors to observe the inside of the patient's body in real time during minimally invasive, robotic and open surgery. Its application range covers The brain, spine and abdomen. BK Medical is headquartered in Boston and Copenhagen and has more than 650 employees. The transaction is expected to further strengthen the potential value of BK Medical, including the significant synergies brought by the use of GE's technology and commercial scale.
GE Medical expects that after the cooperation, BK Medical will achieve rapid revenue growth, profit margin expansion and free cash flow growth. GE Healthcare also predicts that the return on investment capital will reach high single digits in the fifth year. The two parties expect the transaction to be completed in 2022, but subject to review by relevant regulatory agencies. This transaction enables BK Medical’s Active Imaging platform to reach a wider range of new customers and new markets around the world. The combination of GE Medical’s diagnostic imaging technology and BK Medical`s ability to achieve decision-making and surgical visualization during interventions will help in the entire Make better clinical decisions during the nursing process.
According to the company, GE's medical ultrasound product portfolio generated US$3 billion in revenue before the 2019 COVID-19 pandemic. The market demand for heart and lung diagnostic probes at the bedside is expected to follow the spread of the COVID-19 epidemic. And continue to increase.
Earlier this year, the medical technology giant launched two diagnostic ultrasound devices, one for COVID-19 wards and the other for a new type of pocket wireless probe. Venue Fit, which can be installed on a cart, contains artificial intelligence software that can automatically measure the patient's heart strength and pneumonia symptoms, and help scan the heart, lungs and kidneys for signs of complications of the new coronavirus. At the same time, the handheld Vscan Air can also be directly connected to a smart phone, and uses a double-sided dual probe design, which can be used for shallow and deep tissue imaging.